Rapid changes resulting from personalized medicine, including the ability to use individual patient biomarker data to generate a tailored treatment, are transforming healthcare.
The question of whether to pay the directors of a tax-exempt organization is hotly contested.
Advances in medical technology have increased the use of diagnostic tests to guide therapeutic decisions for many diseases and conditions, especially in the context of personalized medicine.
Monday Morning Regulatory Review: Obamacare Tax Subsidies Intercircuit Conflict & COOL First Amendment Regulations
Little new and unexpected agencies activity compels review in the last week, but the courts were fully engaged on two very different, critical regulatory issues.
Earlier this week, a popular source of regulatory news published an article claiming FDA “finalized a new rule this week that prohibits manufacturers from using so-called “split-predicates”.
On July 29, 2014, the Institute of Medicine of the National Academies (IOM) released a report on Graduate Medical Education (GME), entitled Graduate Medical Education That Meets the Nation’s Health Needs.
Hospital emergency rooms are our first line of defense for actual attacks and emergencies, but in some cases ERs are finding themselves literally under cyber-attack.
How Two Courts of Appeals Applied the Same Law to Reach Opposite Conclusions About the Affordable Care Act
Last week, two federal courts of appeals–the 4th Circuit and D.C. Circuit–considered whether the IRS reasonably interpreted the Affordable Care Act as allowing the IRS to give tax credits to taxpayers that purchase health insurance through an exchange set up by the federal government.
As we have discussed in prior posts, many employers are looking at ways to restructure their workforces due to the ACA.
Our most recent post on the issue was entitled “Two More ADA Lawsuits Filed By The EEOC: Guess Which Companies Got Sued?” The title refers to our repeated posts asking why the EEOC seems to target health care companies for ADA lawsuits.